Actively Recruiting
Study Comparing ACUVUE4 OASYS MAX 1-Day Multifocal and DAILIES4 AquaComfort Plus4 Multifocal Contact Lenses for Visual Acuity
Led by Johnson & Johnson Vision Care, Inc. · Updated on 2026-11-03
150
Participants Needed
11
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to compare the safety and effectiveness of two types of multifocal contact lenses, ACUVUE4 OASYS MAX 1-Day Multifocal and DAILIES4 AquaComfort Plus4 Multifocal. The study is designed as a randomized, single-masked clinical trial with two parallel groups to evaluate visual acuity and ocular safety in adults aged 40 to 70 years. Participants will be monitored for both near and distance vision performance as well as any lens-related eye events. Participants will be randomly assigned to wear either the Senofilcon A lens ACUVUE4 OASYS MAX 1-Day Multifocal or the Nelfilcon A lens DAILIES4 AquaComfort Plus4 Multifocal for the duration of the study. The study consists of four visits where the lenses performance is assessed at one week and one month after initial fitting. Both lenses are soft multifocal contact lenses designed to correct presbyopia and improve visual acuity at various distances. During the study, participants will undergo evaluations of binocular visual acuity at distance, intermediate, and near ranges, along with monitoring for ocular adverse events and slit lamp findings. The primary outcomes measured include visual acuity at one week and the incidence of lens-related eye issues up to one month. This study requires participants to attend four visits over the course of the study period, which lasts approximately one month after lens fitting.
CONDITIONS
Brief Title
Comparison of ACUVUE® OASYS MAX 1-Day Multifocal and DAILIES® AquaComfort Plus® Multifocal
Research Team
S
Study Contact
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here